Business
Covalon Receives Final TSXV Approval for Previously Announced Private Placement and Announces Issuance of Stock Options
MISSISSAUGA, ON , Sept. 27, 2013 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Co...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n\n\n\nMISSISSAUGA, ON, Sept. 27, 2013 /CNW/ - Covalon Technologies Ltd. (the\n \"Company\" or \"Covalon\") (TSXV: COV), an advanced medical technologies\n company, today announced that it has received final approval from the\n TSX Venture Exchange for its previously announced non-brokered private\n placement comprised of 750 units (the \"Units\") at a price of $1,000 per\n Unit for gross proceeds of $750,000, which was announced on August 16,\n 2013.\n\n\nThe Company also announced that, subject to regulatory approval, Covalon\n has granted 309,500 stock options (\"options\") to directors, officers\n and staff of the Company. The options issued to directors and officers\n have an exercise price of $0.85 per common share, will vest over the\n next three years and are valid for a period of five years from the date\n of grant. The options were granted in accordance with the Company's\n stock option plan re-approved by shareholders on June 13, 2013.\n\n\nAbout Covalon \n\n\nCovalon Technologies Ltd. researches, develops and commercializes new\n healthcare technologies that help save lives around the world.\n Covalon's patented technologies, products and services address the\n advanced healthcare needs of medical device companies, healthcare\n providers and individual consumers. Covalon's technologies are used to\n prevent, detect and manage medical conditions in specialty areas such\n as wound care, tissue repair, infection control, disease management,\n medical device coatings and biocompatibility. To learn more about\n Covalon, visit our website at www.covalon.com\n\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as\n that term is defined in the policies of the TSX Venture Exchange)\n accepts responsibility for the adequacy or accuracy of this release. \n\n\nThis news release contains forward-looking statements which reflect the\n Company's current expectations regarding future events. The\n forward-looking statements are often, but not always, identified by the\n use of words such as \"seek\", \"anticipate\", \"plan, \"estimate\", \"expect\",\n \"intend\" and statements that an event or result \"may\", \"will\",\n \"should\", \"could\" or \"might\" occur or be achieved and other similar\n expressions. These forward-looking statements involve risk and\n uncertainties, including the difficulty in predicting ...